Experimental drug shows early promise against inherited form of ALS, trial indicates
A clinical trial has found evidence that the experimental drug tofersen lowers levels of a disease-causing protein in people with an inherited form of amyotrophic lateral sclerosis, or ALS, caused by mutations in the gene SOD1.
from Latest Science News -- ScienceDaily https://ift.tt/2VZTQDU
from Latest Science News -- ScienceDaily https://ift.tt/2VZTQDU
0 Response to "Experimental drug shows early promise against inherited form of ALS, trial indicates"
Post a Comment